Back
Goldman Sachs S&P 500 Premium Income ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
57
GPIX
Goldman Sachs S&P 500 Premium Income ETF
Last Price:
$52.06
Seasonality Move:
-0.32%
Buy
64
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$88.61
Seasonality Move:
-30.03%
Buy
57
Goldman Sachs S&P 500 Premium Income ETF (GPIX)
is a Buy
Is Goldman Sachs S&P 500 Premium Income ETF a Buy, Sell or Hold?
-
The current Goldman Sachs S&P 500 Premium Income ETF [GPIX] share price is $52.35. The Score for GPIX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
GPIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $93.99. The Score for DRUG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GPIX Stock Price Chart
What is Goldman Sachs S&P 500 Premium Income ETF's stock price today?
-
The Goldman Sachs S&P 500 Premium Income ETF share price today is $52.35The current trend is moderately bearish and GPIX is experiencing slight buying pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $93.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.
GPIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 49.16 | Sell |
| Chaikin Money Flow: | 187200 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.7 - 52.86) | Buy |
| Bollinger Bands (100): | (50.88 - 52.58) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.78 | Buy |
| Relative Strength Index (14 RSI): | 76.13 | Buy |
| Chaikin Money Flow: | 147064 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.66 - 81.44) | Buy |
| Bollinger Bands (100): | (40.97 - 68.09) | Buy |
GPIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.63 | Sell |
| 20-day SMA: | 52.28 | Buy |
| 50-day SMA: | 52.3 | Buy |
| 200-day SMA: | 49.58 | Buy |
| 8-day EMA: | 52.55 | Sell |
| 20-day EMA: | 52.45 | Sell |
| 50-day EMA: | 52.21 | Buy |
| 200-day EMA: | 50.52 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.53 | Buy |
| 20-day SMA: | 72.88 | Buy |
| 50-day SMA: | 64.83 | Buy |
| 200-day SMA: | 42.54 | Buy |
| 8-day EMA: | 84.37 | Buy |
| 20-day EMA: | 75.93 | Buy |
| 50-day EMA: | 66.06 | Buy |
| 200-day EMA: | 46.89 | Buy |
Goldman Sachs S&P 500 Premium Income ETF Earnings Growth & GPIX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
Goldman Sachs S&P 500 Premium Income ETF Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||